These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27485003)

  • 21. Measuring error rates in genomic perturbation screens: gold standards for human functional genomics.
    Hart T; Brown KR; Sircoulomb F; Rottapel R; Moffat J
    Mol Syst Biol; 2014 Jul; 10(7):733. PubMed ID: 24987113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CRISPR Growth Spurt: from Bench to Clinic on Versatile Small RNAs.
    Bayat H; Omidi M; Rajabibazl M; Sabri S; Rahimpour A
    J Microbiol Biotechnol; 2017 Feb; 27(2):207-218. PubMed ID: 27840399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applications of CRISPR-Cas systems in neuroscience.
    Heidenreich M; Zhang F
    Nat Rev Neurosci; 2016 Jan; 17(1):36-44. PubMed ID: 26656253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR-Based System Uncovers Key Regulators of Disease-Related Genes.
    Hampton T
    JAMA; 2017 Aug; 318(5):412-413. PubMed ID: 28763528
    [No Abstract]   [Full Text] [Related]  

  • 25. CRISPR/Cas9 for genome editing: progress, implications and challenges.
    Zhang F; Wen Y; Guo X
    Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Not Available].
    Nau JY
    Rev Med Suisse; 2016 Apr; 12(514):766-7. PubMed ID: 27263157
    [No Abstract]   [Full Text] [Related]  

  • 27. CRISPR/Cas9-Based Positive Screens for Cancer-Related Traits.
    Slipek NJ; Varshney J; Largaespada DA
    Methods Mol Biol; 2019; 1907():137-144. PubMed ID: 30542997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technique: CRISPR CAPTURE for multi-omic probing of genomic loci.
    Burgess DJ
    Nat Rev Genet; 2017 Nov; 18(11):641. PubMed ID: 28970588
    [No Abstract]   [Full Text] [Related]  

  • 29. Modeling CRISPR-Cas13d on-target and off-target effects using machine learning approaches.
    Cheng X; Li Z; Shan R; Li Z; Wang S; Zhao W; Zhang H; Chao L; Peng J; Fei T; Li W
    Nat Commun; 2023 Feb; 14(1):752. PubMed ID: 36765063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recovering false negatives in CRISPR fitness screens with JLOE.
    Dede M; Hart T
    Nucleic Acids Res; 2023 Feb; 51(4):1637-1651. PubMed ID: 36727483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic screens: CRISPR-based mapping of genetic interactions.
    Cloney R
    Nat Rev Genet; 2017 May; 18(5):272-273. PubMed ID: 28366937
    [No Abstract]   [Full Text] [Related]  

  • 32. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
    Mashimo T
    Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional Analysis of Porphyromonas gingivalis W83 CRISPR-Cas Systems.
    Burmistrz M; Dudek B; Staniec D; Rodriguez Martinez JI; Bochtler M; Potempa J; Pyrc K
    J Bacteriol; 2015 Aug; 197(16):2631-41. PubMed ID: 26013482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR/Cas9: molecular tool for gene therapy to target genome and epigenome in the treatment of lung cancer.
    Sachdeva M; Sachdeva N; Pal M; Gupta N; Khan IA; Majumdar M; Tiwari A
    Cancer Gene Ther; 2015 Nov; 22(11):509-17. PubMed ID: 26494554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR-based screening of genomic island excision events in bacteria.
    Selle K; Klaenhammer TR; Barrangou R
    Proc Natl Acad Sci U S A; 2015 Jun; 112(26):8076-81. PubMed ID: 26080436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR-Cas Systems in Prokaryotes.
    Burmistrz M; Pyrć K
    Pol J Microbiol; 2015; 64(3):193-202. PubMed ID: 26638527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pooled Lentiviral-Delivery Genetic Screens.
    Piccioni F; Younger ST; Root DE
    Curr Protoc Mol Biol; 2018 Jan; 121():32.1.1-32.1.21. PubMed ID: 29337374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applications of the CRISPR/Cas9 system in murine cancer modeling.
    Zuckermann M; Kawauchi D; Gronych J
    Brief Funct Genomics; 2017 Jan; 16(1):25-33. PubMed ID: 27273122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods.
    Jo YI; Suresh B; Kim H; Ramakrishna S
    Biochim Biophys Acta; 2015 Dec; 1856(2):234-43. PubMed ID: 26434948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editing and investigating genomes with TALE and CRISPR/Cas systems: applications of artificial TALE and CRISPR-Cas systems.
    Giovannangeli C; Concordet JP
    Methods; 2014 Sep; 69(2):119-20. PubMed ID: 25248487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.